PurposeThis paper aims to examine the performance of Islamic and conventional stocks listed at the Pakistan Stock Exchange by using both parametric and non-parametric approaches. The motivation is to do risk-return analysis of Islamic stock prices and conventional stock prices.Design/methodology/approachIt uses various measures of performance, e.g. Sharpe ratio, Treynor ratio, Jensen's alpha, beta, generalized auto-regressive conditional heteroskedasticity and stochastic dominance. Using the Karachi Meezan Index-30 (KMI-30) and the Karachi Stock Exchange Index-30 (KSE-30) as proxies for Islamic and conventional stock prices, respectively, it examines the performance of Islamic and conventional stocks. The daily data of KMI-30 and KSE-30, covering period from June 9, 2009 to June 20, 2020 are used.FindingsThe results show that the overall KMI-30 outperforms the KSE-30. The returns of the KMI-30 are greater than the KSE-30. However, the risk and volatility of the KMI-30 and KSE-30 are similar. Further, the KMI-30 has higher excess returns per unit of total risk than the KSE-30. But both indexes have similar excess returns per unit of systematic risk. Moreover, the KMI-30 returns have stochastically dominance over the KSE-30 returns. These results reveal that the Islamic index performs better than the conventional index.Practical implicationsThe findings provide several practical implications in financial and investment decisions making by investors, managers and policymakers such as strategies for asset allocation and investment. Further, in risk management, it provides guidance for allocating portfolios and managing risk. The investment in Islamic stocks may mitigate potential risk within asset portfolios.Originality/valueThis research is unique in its approach to the analysis of the performance comparison of conventional and Islamic stock by using comprehensive parametric and non-parametric estimation techniques. Such research has not been undertaken in the Pakistan's equity market since.
In this paper, we first examine the presence of monthly
calendar anomaly in Pakistan Stock Exchange (PSX) using aggregate and
firm-level monthly stock returns. Secondly, we classify the sample firms
into low-beta, medium-beta, and high-beta firms to examine the monthly
anomaly of stock returns for firms having different level of systematic
risk. By considering the stochastic dominance approach (SDA), we employ
the simulation based method of Barrett and Donald (2003) to identify the
dominant month over the period from January 2000 to December 2017. We
find significant evidence of the existence of the January effect in both
firm and market stock returns. We also find that the January effect
exists more prominently in both low-risk and high-risk firms categorised
based on their systematic risk. On the other end of the continuum, for
moderately risky firms, there is strong evidence of the presence of the
December effect. One of possible explanations of the January effect is
the yearend bonus received in the month of January. Such bonuses are
generally used to purchase stocks, causing the bullish trend of stock
prices in January. However, the evidence of the January anomaly in both
low-beta and high-beta portfolios returns is puzzling, suggesting that
investors may invest in both low- and high-risk stocks when
enthusiastically investing in stock market. The findings of the paper
suggest that investors may get abnormal returns by forecasting stock
return patterns and designing their investment strategies by taking into
account the January and December effects and the level of systematic
risk associated with the firms. JEL Classification: G02, G12, G14
Keywords: Behavioural Finance, Stochastic Dominance Approach, Monthly
Anomaly, January Effect, December Effect, TOY Anomaly, Abnormal Returns,
KS Type Test, PSX
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.